For all of the quality care it delivers, the U.S. health care system is one of the most dysfunctional sectors of the U.S. economy. The government spends nearly 50 cents of every dollar spent on health care, most consumers are almost entirely insulated from the cost of their decisions, and employers decide what kind of health insurance their employees get.
But while the U.S. health care system begs for reform, the Patient Protection and Affordable Care Act only exacerbates all of the current problems, promising to devolve into a price-controlled system rationed and micromanaged by bureaucrats.
IPI believes there are much better options: reform the tax treatment of health insurance; remove the state and federal mandates and regulations that make coverage more expensive; pass medical liability reform; and promote policies that create value-conscious shoppers in the health care marketplace.
We agree that health care needs price transparency, and it will come if and when health care consumers, rather than government, demand it.
President Obama boasted he wanted to increase individuals' access to affordable health coverage. President Trump may have just accomplished Obama's goal.
Senators John Cornyn and Richard Blumenthal want to control prescription drug prices by empowering bureaucracy. When has that ever worked?
“From a political standpoint, it is foolish to push importation. If deaths occur, the politician who promoted it will take the blame,” said Merrill Matthews, a resident scholar with the Institute for Policy Innovation.
Sen. John Cornyn's legislation that attempts to address problems he sees with the patent protections afforded to American drug companies overreaches and would limit the ability of pharmaceutical firms to develop and improve medicines.
A new Health and Human Services rule requiring pharmaceutical companies to disclose list prices for medications in commercial advertisements is unlikely to boost price transparency for consumers. In fact, it may create even more confusion.
Democrats' Medicare for All legislation could put a million private sector employees out of a job, which has been a decades-old goal.
If lawmakers want to cut drug spending without leaving patients in the lurch, they’d be wise to foster more competition in the drug marketplace. Price controls
"Planned Parenthood reportedly received about $1.5 billion in taxpayer dollars between 2013-15, most of it from the Medicaid program,” said Dr. Merrill Matthews. “While federal law prohibits that money from being used to provide abortion services, money is fungible. It can be used to pay many of the fixed expenses, freeing up other monies to provide abortion services. Attorney General Paxton's effort to defund Planned Parenthood simply recognizes that financial relationship,” Matthews said.
Eight states are asking a court to strike an Obamacare rule they say violates their authority to protect the judgment and conscience rights of medical professionals.